###begin article-title 0
HOXA13 Is Essential for Placental Vascular Patterning and Labyrinth Endothelial Specification
###end article-title 0
###begin p 1
Conceived and designed the experiments: CS LS HS. Performed the experiments: CS DK HS. Analyzed the data: CS LS DL HS. Contributed reagents/materials/analysis tools: HS. Wrote the paper: CS HS.
###end p 1
###begin p 2
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1121 1135 1121 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2 and Foxf1</italic>
###xml 1203 1207 1203 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1212 1217 1212 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1249 1250 1249 1250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1412 1416 1412 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1421 1426 1421 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1548 1554 1548 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
In eutherian mammals, embryonic growth and survival is dependent on the formation of the placenta, an organ that facilitates the efficient exchange of oxygen, nutrients, and metabolic waste between the maternal and fetal blood supplies. Key to the placenta's function is the formation of its vascular labyrinth, a series of finely branched vessels whose molecular ontogeny remains largely undefined. In this report, we demonstrate that HOXA13 plays an essential role in labyrinth vessel formation. In the absence of HOXA13 function, placental endothelial cell morphology is altered, causing a loss in vessel wall integrity, edema of the embryonic blood vessels, and mid-gestational lethality. Microarray analysis of wild-type and mutant placentas revealed significant changes in endothelial gene expression profiles. Notably, pro-vascular genes, including Tie2 and Foxf1, exhibited reduced expression in the mutant endothelia, which also exhibited elevated expression of genes normally expressed in lymphatic or sinusoidal endothelia. ChIP analysis of HOXA13-DNA complexes in the placenta confirmed that HOXA13 binds the Tie2 and Foxf1 promoters in vivo. In vitro, HOXA13 binds sequences present in the Tie2 and Foxf1 promoters with high affinity (Kd = 27-42 nM) and HOXA13 can use these bound promoter regions to direct gene expression. Taken together, these findings demonstrate that HOXA13 directly regulates Tie2 and Foxf1 in the placental labyrinth endothelia, providing a functional explanation for the mid-gestational lethality exhibited by Hoxa13 mutant embryos as well as a novel transcriptional program necessary for the specification of the labyrinth vascular endothelia.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 765 770 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 788 792 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 912 921 912 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro,</italic>
###xml 1015 1019 1015 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1024 1029 1024 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
Defects in placental development are a common cause of mid-gestational lethality. Key to the placenta's function is its vascular labyrinth, a series of finely branched vessels that facilitate the efficient exchange of gases, nutrients, and metabolic waste between the maternal and fetal blood supplies. In this study, we identify a novel role for the transcription factor HOXA13 in formation of the placental vascular labyrinth. In the absence of HOXA13 function, labyrinth vessel branching and endothelial specification is compromised, causing mid-gestational lethality due to placental insufficiency. Analysis of the genes affected by the loss of HOXA13 function revealed significant reductions in the expression of several pro-vascular genes, including Tie2 and Foxf1. Analysis of the Tie2 and Foxf1 promoters confirmed that HOXA13 binds sites present in each promoter with high affinity in the placenta, and in vitro, HOXA13 can use these bound sequences to regulate gene expression. These results suggest that Tie2 and Foxf1 are direct transcriptional targets of HOXA13 in the developing placental labyrinth, providing a novel transcriptional pathway to consider when examining pathologies of the placenta and placental insufficiency, as well as the evolutionary mechanisms required for the emergence of the vascular placenta in eutherian mammals.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Rossant1">[1]</xref>
###xml 670 673 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Breier1">[2]</xref>
###xml 674 677 674 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Downs4">[7]</xref>
###xml 925 928 925 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Abbott1">[8]</xref>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Zhang1">[16]</xref>
###xml 1220 1223 1220 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Cross1">[3]</xref>
###xml 1225 1229 1225 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Beck1">[17]</xref>
###xml 1230 1234 1230 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Withington1">[26]</xref>
###xml 1757 1761 1757 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1766 1771 1766 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
For placental mammals, fetal development is contained in an intrauterine environment where the efficient exchange of oxygen, nutrients, and metabolic waste between the maternal and fetal blood supplies is facilitated by the placenta. Central to the placenta's function is its vascular labyrinth, a juxtaposed series of finely-branched blood vessels and trophoblasts that regulate nutrient and waste exchange while maintaining the separation of the maternal and fetal blood supplies [1]. After implantation, labyrinth vascularization proceeds from the allantois, where angiogenic and vasculogenic processes promote the formation of a dense, highly arborized vascular bed [2]-[7]. The formation of the labyrinth vascular bed requires many of the same signals controlling embryonic vascular development including: VEGF and its associated receptors FLT1, FLK1, and NEUROPILIN-1, as well as ANG-1 and ANG-2 and its receptor TIE-2 [8]-[16]. Interestingly, while loss of function studies clearly demonstrate that transcription factors such as: TBX4, CDX2, CDX4, HAND1, DLX3, FOXF1, and CITED2 are required for placental development, the target genes regulated by these proteins in the developing placenta are largely undefined [3], [17]-[26]. In this report, we describe a novel role for HOXA13 in the developing placenta and identify both direct and indirect targets of HOXA13 functioning in the placental labyrinth endothelia. In the absence of HOXA13 function, labyrinth endothelial cell morphology, vessel branching, and vessel integrity are compromised, a consequence we attribute to a loss in the regulation of several essential pro-vascular genes. Chromatin immunoprecipitation of the HOXA13-DNA complexes confirmed that HOXA13 directly associates with the Tie2 and Foxf1 promoters in vivo in the developing placenta. Quantitation of HOXA13's affinity for these promoter regions confirmed that HOXA13 binds these regions with high affinity and can utilize these bound DNA sequences to facilitate gene expression in vitro. Together these findings reveal a novel temporal and spatial domain for HOXA13 function in the developing embryo and identify a key transcriptional hierarchy necessary for the development of the placental vascular labyrinth.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Hoxa13 Is Expressed Throughout Placental Labyrinth Development
###end title 8
###begin p 9
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-FromentalRamain1">[27]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 392 408 392 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g001">Figure 1A and 1B</xref>
###xml 670 676 670 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Chen1">[30]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Lee1">[34]</xref>
###xml 1031 1044 1031 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g001">Figures 1C&#8211;1G</xref>
###xml 1049 1050 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">2</xref>
###xml 1141 1151 1141 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g001">Figures 1H</xref>
###xml 1156 1157 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">2</xref>
###xml 1251 1264 1251 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g001">Figures 1E&#8211;1H</xref>
###xml 1266 1267 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">2</xref>
###xml 13 19 <span type="species:ncbi:10090">murine</span>
Among the 39 murine Hox genes, only mutations in Hoxa13 cause mid-gestational lethality from embryonic day (E) 11-15.5 [27]-[29]. Initially, this phenotype was attributed to premature stenosis of the umbilical arteries [29]. Extensive analysis of the umbilical artery (UA) defect in Hoxa13 homozygous mutants revealed that only one of the two UAs exhibited complete stenosis from E11.5-15.5 (Figure 1A and 1B). This finding prompted the hypothesis that an additional defect must be contributing to the mid-gestational lethality. Because malformations of the heart and placenta are the most commonly cited reasons for mid-gestational lethality, we first examined whether Hoxa13 is expressed in the developing heart or placenta [30]-[34]. No HOXA13 expression was detected in the cardiac crescent; however, the earliest component of the placenta, the allantoic bud mesoderm, strongly expressed HOXA13 from E7.75 and maintained expression in the maturing allantois and developing labyrinth microvessels at E8.5 and E9.5 respectively (Figures 1C-1G and 2). At E10.5, HOXA13 expression was readily detected in the developing placental labyrinth (Figures 1H and 2) whereas the chorionic ectoderm exhibited little or no HOXA13 expression from E9.5 to E10.5 (Figures 1E-1H, 2). To note, the timing and occurrence of chorioallantoic fusion was unaffected by the loss of HOXA13 function (data not shown).
###end p 9
###begin title 10
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Early expression of Hoxa13 in the allantois and its derivatives.
###end title 10
###begin p 11
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
(A, B) HOXA13 is expressed in the umbilical arteries which partially stenose (white arrow) in Hoxa13 homozygous mutants. (C) Fluorescent and bright field image of an E7.75 embryo expressing HOXA13-GFP. AL = allantois, CC = cardiac crescent. (D) HOXA13-GFP is expressed throughout the allantois at E8.5. Red signal = detection of the HOXA13-GFP fusion protein using a GFP antibody (denoted as alpha-GFP). Green signal indicates detection of the endogenous HOXA13-GFP fusion protein. Yellow signal (Merged) indicates the co-localization of the detected HOXA13-GFP protein and the alpha-GFP immuno-positive cells, confirming the detected green fluorescence to be derived from the mutant HOXA13-GFP fusion protein throughout the allantois. AL = allantois; EM = embryo proper. (E, F) Cryosection of an E9.5 placenta. Green signal indicates detection of the HOXA13-GFP fusion protein in the developing labyrinth region; red signal indicates detection of the HOXA13-GFP fusion protein using a GFP antibody (denoted as alpha-GFP). Note the absence of HOXA13-GFP expression in the chorionic ectoderm (CE). Arrows denote sites of microvessel genesis. Dashed line represents chorionic plate. AS = allantoic stalk. (G) Sagittal section of an E9.5 embryo and developing placenta. Note that HOXA13-GFP expression is maintained in the allantoic stalk as it contributes to the developing allantoic vessels (arrows) as well as the developing chorionic plate vessels (asterisks). Dashed line denotes the developing chorionic plate. CE = chorionic ectoderm, EM = embryo proper, AS = allantoic stalk. (H) At E10.5, HOXA13 expression is maintained in the developing labyrinth (LAB), whereas little or no expression is detected in the chorionic ectoderm (CE). Bars are 25 microm.
###end p 11
###begin title 12
Sites of HOXA13 expression during placental labyrinth development.
###end title 12
###begin p 13
(A) HOXA13 is expressed in the endothelial progenitors in the E8.0 allantois. (B) HOXA13 expression is maintained in the endothelial progenitors during chorioallantoic fusion at E8.5. (C) Between E8.75 and E9.5, the HOXA13-expressing endothelial progenitors contribute to the developing feto-placental vessels, which mature to form the umbilical artery (UA), chorionic plate vessels, and the vessels contributing to the placental labyrinth (D). HOXA13 is not expressed in the developing umbilical vein (UV).
###end p 13
###begin title 14
HOXA13 Functions in the Labyrinth Vascular Endothelia
###end title 14
###begin p 15
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figure 3</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Muller1">[35]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-vanMourik1">[37]</xref>
###xml 411 423 411 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figure 3A&#8211;3F</xref>
###xml 716 732 716 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figure 3C and 3D</xref>
###xml 828 844 828 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figure 3E and 3F</xref>
###xml 972 988 972 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figure 3E and 3F</xref>
###xml 1233 1245 1233 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figure 3C&#8211;3F</xref>
###xml 1572 1584 1572 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">Figure 4A&#8211;4D</xref>
###xml 1888 1900 1888 1900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">Figure 4A&#8211;4D</xref>
To determine the identity of the cells expressing HOXA13 in developing labyrinth, we examined whether these cells co-express the endothelial marker PECAM-1 (Figure 3) [35]-[37]. Characterization of HOXA13 and PECAM-1 expression confirmed that only the cells expressing PECAM-1 (cell surface) also express HOXA13 (nucleus), suggesting that HOXA13 is functioning in the labyrinth vascular endothelial cells (EC) (Figure 3A-3F). HOXA13 expression was not detected in the placental trophoblasts (data not shown). Interestingly, the elongated morphology normally attributed to the labyrinth vascular endothelia was also affected in homozygous mutants, which appeared rounded compared to controls in the E12.5 labyrinths (Figure 3C and 3D). To determine the onset of the EC phenotype, we characterized the labyrinth vessels at E10.5 (Figure 3E and 3F). At E10.5, the EC in both the heterozygous control and homozygous mutant labyrinths exhibited only the rounded EC morphology (Figure 3E and 3F). This result suggests that the vascular specification of the EC, as indicated by their elongated morphology, occurs between E10.5 and E12.5 and denotes when the loss of HOXA13 function phenotype first manifests in the developing labyrinth EC (Figure 3C-3F). Close examination of the affected EC using transmission electron microscopy confirmed the timing of the onset of this phenotype as wild type EC exhibited lengthening of the cell body as early at E11.5 whereas homozygous mutant EC exhibited shortened cell bodies that lacked uniform contact with the underlying vessel walls (Figure 4A-4D). Finally, consistent with the reduction in the EC cell body was the loss of vessel wall integrity in the E11.5 and E13.5 mutant vessels, resulting in extracellular edema between mutant labyrinth vessels and the underlying syncytiotrophoblasts, while edema was not detected in the wild type labyrinths (Figure 4A-4D).
###end p 15
###begin title 16
HOXA13 is expressed in the placental labyrinth vascular endothelia.
###end title 16
###begin p 17
(A, B) Analysis of HOXA13 expression (green) in heterozygous control and homozygous mutant placentas at E12.5 reveals extensive expression throughout the vascular labyrinth. (C) HOXA13 is co-expressed with PECAM-1 in the labyrinth endothelia, which exhibit an elongated morphology in heterozygous controls (arrowheads). (D) E12.5 homozygous mutant labyrinth endothelia also express HOXA13 (green signal) and PECAM-1 (red signal), but maintain a rounded morphology (arrowheads). (E, F) Analysis of labyrinth vessels at E10.5 reveals co-localization of HOXA13 (green signal) and PECAM-1 (red signal) to the undifferentiated endothelia (arrowheads), which do not exhibit an elongated vascular morphology. Bar is 10 microm for (C-F).
###end p 17
###begin title 18
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Endothelial cell morphology is affected in the placental labyrinth of Hoxa13 homozygous mutants.
###end title 18
###begin p 19
(A, B) Transmission electron microscopy (TEM) reveals the initial elongation of the wild-type EC in the developing labyrinth vessels, whereas homozygous mutant littermates (B) exhibit rounded endothelia with attenuated cell bodies. Asterisks denote the endothelial cells; arrows depict the EC bodies in wild-type and mutant vessels. (C, D) Wild-type controls exhibit a mature elongated endothelial cell morphology by E13.5 (arrows), whereas homozygous mutant littermates (D) exhibit a severe loss in the elongated morphology (arrows), causing edema in the surrounding placental tissues (arrowheads). F = fetal vessel lumen; M = maternal space. (E, F) No differences in basement membrane (arrows) ultrastructure were detected in the labyrinth vessels between wild-type and homozygous mutant embryos, confirming that the loss of HOXA13 function is directly affecting endothelial morphology and function. F = fetal vessel lumen; N = endothelial cell nucleus. (G) Quantitative analysis of multiple labyrinth vessel TEM micrographs revealed that nearly 50% of the homozygous mutant endothelia exhibited an intermediate or severely abnormal morphology compared to wild-type or heterozygous mutant controls.
###end p 19
###begin p 20
###xml 115 131 115 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">Figure 4E and 4F</xref>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">Figure 4G</xref>
###xml 485 493 485 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">Figure 4</xref>
No gross morphological defects were observed in the basement membranes between the EC and the syncytiotrophoblast (Figure 4E and 4F). Quantitation of the affected labyrinth EC in the homozygous mutants revealed that nearly 50 percent exhibited an intermediate or grossly affected morphology compared to only 12 percent for age-matched controls (Figure 4G). Finally, the affected EC did not appear apoptotic as the nuclei lacked a pyknotic phenotype as well as TUNEL positive staining (Figure 4 and unpublished data).
###end p 20
###begin title 21
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Labyrinth Vascular Branching and Size Are Reduced in Hoxa13 Homozygous Mutants
###end title 21
###begin p 22
###xml 285 293 285 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">Figure 2</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Demir1">[38]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Patan1">[39]</xref>
###xml 777 786 777 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">Figures 2</xref>
###xml 787 787 787 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003"/>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">4</xref>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Faber1">[40]</xref>
###xml 795 799 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Zeng1">[47]</xref>
###xml 303 309 <span type="species:ncbi:10090">murine</span>
As the umbilical vessels cross the chorionic plate, they exhibit non-sprouting angiogenesis parallel to the chorionic plate to produce the chorionic plate vessels, followed by additional EC migration and branching angiogenesis into the labyrinth to create a complex vascular tree (see Figure 2). In the murine placental labyrinth, these vascular branches are interconnected, signifying that intussusceptive angiogenesis and vessel fusion also play a role in their angiogenic remodeling [38],[39]. Recognizing that EC mediate many of the angiogenic processes necessary for vessel remodeling and branching, we hypothesized that defects in the mutant labyrinth EC would affect vessel branching, which would compromise the capacity of this structure to sustain embryonic survival (Figures 2-4) [40]-[47]. To best visualize the branched vasculature within the labyrinth, we utilized whole tissue immunohistochemistry using the PECAM-1 antibody and hemisected placentas.
###end p 22
###begin p 23
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 235 244 235 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000073.s001">Figure S1</xref>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 470 471 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 607 615 601 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g005">Figure 5</xref>
###xml 907 916 901 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g003">Figures 3</xref>
###xml 918 919 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g005">5</xref>
###xml 925 927 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000073.s001">S1</xref>
###xml 929 933 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Suzuki1">[48]</xref>
###xml 1084 1090 1078 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1171 1177 1165 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1337 1345 1319 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g006">Figure 6</xref>
Indeed, while the initial vascular invasion of the chorionic plate at E10.5 appears normal in Hoxa13 homozygous mutants, there is a qualitative reduction in the level of PECAM-1 staining of the labyrinth vasculature as early as E11.5 (Figure S1). Quantitation of the vascular branches in the mutant and control placental labyrinths at E13.5 confirmed that the number of branches is reduced in the Hoxa13 homozygous mutants which exhibited 33 (+/-6.3) branches per 400 mm2 grid analyzed, whereas wild type and heterozygous mutant controls contained 56 (+/-12.7) and 55 (+/-9.7) vessel branches respectively (Figure 5). Qualitatively, the reduction in labyrinth vascularity in homozygous mutants was persistent throughout labyrinth development which is complete by E14.5, suggesting that decreased vessel branching is phenotypic of the loss of HOXA13 function rather than a delay in the labyrinth maturation (Figures 3, 5, and S1) [48]. Next, because changes in vessel branching can also affect the overall size of the labyrinth, we examined whether the labyrinth region was smaller in Hoxa13 mutant placentas. Analysis of labyrinth sections taken from E13.5 wild type and Hoxa13 homozygous mutants confirmed that the mutant labyrinths were nearly half the thickness as their age-matched controls (800+/-200 microm vs. 1600+/-250 microm) (Figure 6).
###end p 23
###begin title 24
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Labyrinth vessel branching is reduced in Hoxa13 homozygous mutants.
###end title 24
###begin p 25
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
(A-D) PECAM-1 immunostaining of E13.5 hemisected placentas revealed extensive branching of the primary labyrinth vessel in wild-type and heterozygous mutants, whereas homozygous mutant littermates exhibited poor branching of the primary labyrinth vessels (E, F). (G) Quantitation of the labyrinth vascular branches confirmed that the homozygous mutants labyrinths contained an average of 33 branches per 400 mm2 grid, whereas wild-type and heterozygous mutant controls contained an average of 56 and 55 branches, respectively, in the same unit area. Bars represent the standard deviation of six independent assessments.
###end p 25
###begin title 26
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
The vascular labyrinth region is thinner in Hoxa13 homozygous mutant placentas.
###end title 26
###begin p 27
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpbp</italic>
###xml 191 197 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 255 261 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
(A), (C) Measurements of the E12.5 labyrinth, which is defined as the region underlying the spongiotrophoblast marker, Tpbp, revealed an average labyrinth thickness of nearly 1,600 microm in Hoxa13 control embryos. (B, C) Parallel analyses of age-matched Hoxa13 homozygous mutants confirmed that the labyrinth thickness is reduced to an average thickness of 800 microm. Arrows represent the sites measured on each labyrinth section from the spongiotrophoblast to the chorionic plate to determine labyrinth thickness using the NIH Image J software. Error bars represent the standard deviation of 16 different labyrinth sections measured at 5 independent points for each sample.
###end p 27
###begin p 28
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 214 222 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g007">Figure 7</xref>
###xml 379 409 379 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g007">Figure 7A and 7B and 7D and 7E</xref>
###xml 587 603 587 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g007">Figure 7C and 7F</xref>
###xml 713 721 713 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Since defects in endothelial cell migration can also contribute to perturbations in vessel branching, we examined whether Hoxa13 mutant endothelia were competent to migrate and participate in de novo angiogenesis (Figure 7). A comparison of mutant and heterozygous control cultured arterial sections revealed comparable levels of neo-vessel production after five days of growth (Figure 7A and 7B and 7D and 7E). Characterization of the cells contributing to the neo-vessels revealed strong HOXA13 expression in the PECAM-1 positive endothelia in both heterozygous and homozygous mutant (Figure 7C and 7F). This result suggests that endothelial cell migration is not affected by the loss of HOXA13 function in the in vitro angiogenesis assay.
###end p 28
###begin title 29
Analysis of endothelial cell migration and neovascularization in cultured placental primary arteries.
###end title 29
###begin p 30
(A, B), (D, E) Arterial sections from heterozygous control and homozygous mutants exhibit robust neovascularization and microvessel formation in vitro. Black boxes denote the sites examined by confocal microscopy to visualize migrating endothelia participating in microvessel formation. (C), (F) The loss of HOXA13 function does not affect the migration and contribution of HOXA13-expressing endothelia (green nuclei) to the developing microvessels. Note that the migrating endothelia co-express PECAM-1 (red signal). Bar is 25 microm.
###end p 30
###begin p 31
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Adams1">[49]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Yang1">[53]</xref>
###xml 548 556 548 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g008">Figure 8</xref>
###xml 857 866 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g008">Figure 8C</xref>
###xml 871 873 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g004">4D</xref>
Taken together, these results suggest that placental insufficiency caused by decreased labyrinth vascularity and size may be causing the mid-gestational lethality associated with the loss of HOXA13 function. To test this hypothesis we examined the developing heart, an organ that does not express Hoxa13 but is severely affected by placental insufficiency [28], [29], [49]-[53]. Analysis of E14.5 hearts from heterozygous control and homozygous mutants revealed a substantial thinning of the right and left ventricular walls in homozygous mutants (Figure 8). Quantitation of the left ventricular wall thicknesses confirmed nearly a 43% reduction in wall thicknesses in homozygous mutants which contained an average of 3.6 (+/-1.1) cells per wall section measurement versus 6.3 (+/-0.8) cells in the comparable sections of age-matched heterozygous controls (Figure 8C and 4D).
###end p 31
###begin title 32
Analysis of ventricular wall thickness in Hoxa13 mutants.
###end title 32
###begin p 33
(A, B) Analysis of hematoxylin and eosin-stained sections (7 microm) from heterozygous control and homozygous mutant hearts at E14.5 embryos reveal qualitatively thicker ventricular walls in the heterozygous control embryos. RV = right ventricle; LV = left ventricle. Boxes represent the enlarged regions shown in (C) and (D). (C, D) Quantitative analysis of the left ventricular wall thicknesses revealed homozygous mutants possess an average of 3.6 (+/-1.1) cells per linear assessment versus 6.3 (+/-0.8) cells in heterozygous controls, confirming that the E14.5 Hoxa13 homozygous mutants possess a thinner left ventricular wall compared to age-matched heterozygous controls. White arrows depict the sites assessed for ventricular wall thickness using the hematoxylin-stained nuclei to determine cell number. The measurements were taken from the trabecular wall (T) to the outer ventricular wall (VW) for each assessment.
###end p 33
###begin title 34
The Loss of HOXA13 Function Causes Mis-Expression of Pro-Vascular and Non-Capillary Endothelial Genes
###end title 34
###begin p 35
###xml 466 528 464 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36, necdin, Enpp2, Adrb1, Tie2, Foxf1, Neuropilin-1, Magel-2</italic>
###xml 534 544 532 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caveolin-1</italic>
###xml 546 553 544 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000073-t001">Table 1</xref>
###xml 732 762 730 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyve-1, Igfbp3, Selenbp1, Bmp1</italic>
###xml 768 773 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ednrb</italic>
###xml 775 782 773 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000073-t002">Table 2</xref>
###xml 784 788 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Dubuisson1">[54]</xref>
###xml 789 793 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Novosyadlyy1">[58]</xref>
###xml 862 866 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gcm1</italic>
###xml 892 896 890 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">esx1</italic>
###xml 923 927 921 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tpbp</italic>
###xml 950 953 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
###xml 983 986 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id2</italic>
###xml 1078 1084 1076 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1116 1124 1112 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g006">Figure 6</xref>
###xml 1129 1136 1125 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000073-t003">Table 3</xref>
###xml 1138 1142 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Liu1">[59]</xref>
###xml 1143 1147 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Li1">[63]</xref>
To identify candidate HOXA13 target genes which are functioning in the placental labyrinth, we performed microarray analysis on E13.5 labyrinth tissues. Twelve microarray hybridizations (6 mutant; 6 wild type) were performed using independent isolates of placental labyrinth total RNA. Statistical analysis of the gene expression signals detected by the microarray probe sets identified significant reductions in pro-vascular gene expression (FDR</=0.05) including: CD36, necdin, Enpp2, Adrb1, Tie2, Foxf1, Neuropilin-1, Magel-2, and Caveolin-1 (Table 1). Interestingly, the homozygous mutant placentas also exhibited significant over-expression of several genes normally expressed in sinusoidal and lymphatic endothelia including: Lyve-1, Igfbp3, Selenbp1, Bmp1, and Ednrb (Table 2) [54]-[58]. Finally, genes expressed in specific trophoblast lineages such as: gcm1 (chorionic trophoblast), esx1 (labyrinth trophoblasts), tpbp (spongiotrophoblast), Id1 (chorionic trophoblast), and Id2 (chorionic trophoblast) exhibited no significant changes in expression between control and Hoxa13 mutant placentas (FDR</=0.05) (Figure 6 and Table 3) [59]-[63].
###end p 35
###begin title 36
Microarray and qRT-PCR analysis of gene transcription comparing mutant and wild-type tissue.
###end title 36
###begin title 37
Loss of HOXA13 function causes increased sinusoidal and lymphatic endothelial gene expression.
###end title 37
###begin title 38
Loss of HOXA13 function does not affect trophoblast gene expression.
###end title 38
###begin p 39
###xml 365 372 365 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000073-t001">Table 1</xref>
###xml 780 789 780 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g009">Figures 9</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000073.s001">S1</xref>
###xml 798 805 798 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000073-t001">Table 1</xref>
###xml 985 998 985 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g009">Figures 9A&#8211;9D</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000073.s001">S1</xref>
Next, to validate that the genes detected by the microarray analysis were mis-expressed in the affected EC, we performed quantitative real-time PCR (qRT-PCR) using total RNA derived from affinity purified vascular labyrinth EC. In all cases, the mis-expression trend determined by the microarray analysis (increased or decreased in mutant placentas) was conserved (Table 1). Moreover, the enrichment of the EC also caused an increase in the detected fold-change differences between wild type and homozygous mutant EC, a finding consistent with an endothelial-specific expression pattern or function for the affected genes. Immunohistochemical analysis of TIE2, LYVE-1, NEUROPILIN-1, and ENPP2 confirmed the altered EC-specific expression levels detected by microarray and qRTPCR (Figures 9 and S1, Table 1, and unpublished data). In particular, the pro-vascular receptor tyrosine kinase, TIE2, was noticeably reduced in the mutant labyrinth EC which also express HOXA13 at E10.5-13.5 (Figures 9A-9D and S1).
###end p 39
###begin title 40
TIE-2 and LYVE-1 are co-expressed with HOXA13 in the labyrinth vascular endothelia and exhibit altered expression in E13.5 homozygous mutants.
###end title 40
###begin p 41
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 511 517 511 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
(A, B) Immunohistochemical analysis of TIE2 expression (red signal) in the placental labyrinth reveals reduced levels in E13.5 Hoxa13 homozygous mutants compared to heterozygous controls. (C, D) Higher magnification image of the placental labyrinth confirms that TIE2 (red signal) is co-expressed with HOXA13 (green nuclear signal) in the labyrinth vascular endothelia. (E, F) Immunohistochemical analysis of LYVE-1 expression (red signal) in the placental labyrinths reveals elevated levels of LYVE-1 in E13.5 Hoxa13 homozygous mutants compared to heterozygous controls. (G, H) Analysis of LYVE-1 expression at higher magnification (red signal) confirms that the PECAM-1-positive endothelial cells (green signal) co-express LYVE-1 and that LYVE-1 expression is elevated in the labyrinth vasculature of Hoxa13 homozygous mutants.
###end p 41
###begin title 42
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
HOXA13 Directly Regulates Tie2 and Foxf1
###end title 42
###begin p 43
###xml 8 22 8 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2 and Foxf1</italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Abbott1">[8]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Patan1">[39]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-GoldmanWohl1">[64]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Sato2">[70]</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 406 419 406 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1 in vivo</italic>
###xml 518 528 518 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10A</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 821 825 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 830 835 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 972 990 972 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10A and 10B</xref>
###xml 1132 1142 1132 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10A</xref>
###xml 1295 1311 1295 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36, Caveolin-1</italic>
###xml 1317 1329 1317 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuropilin-1</italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Because Tie2 and Foxf1 are strongly expressed in the placental labyrinth and mice lacking TIE2 or FOXF1 exhibit vascular defects most similar to those present in Hoxa13 mutant labyrinths, we hypothesized that HOXA13 directly regulates Tie2 or Foxf1 to facilitate labyrinth vascular development [8], [39], [64]-[70]. Testing this hypothesis, we first examined whether HOXA13 binds the promoters for Tie2 or Foxf1 in vivo using a HOXA13 antibody to immunoprecipitate HOXA13-DNA complexes present in labyrinth chromatin (Figure 10A). Previous characterization of the HOXA13 antibody confirmed that it can bind both wild type and mutant HOXA13 proteins and facilitate chromatin immunoprecipitation (ChIP) of HOXA13-bound gene regulatory elements [71]-[73]. PCR analysis of the first 3000 base-pairs (bp) (-3000 to +1) of the Tie2 and Foxf1 promoters revealed a single region in each locus bound by HOXA13 in wild type (not shown) and heterozygous mutant placental labyrinths (Figure 10A and 10B). In contrast, the homozygous mutant HOXA13 protein, which lacks its DNA binding domain, failed to associate with the same promoter regions (Figure 10A). Parallel ChIP assays did not detect HOXA13 association with the promoters of other pro-vascular genes mis-expressed in the mutant labyrinth including CD36, Caveolin-1, and Neuropilin-1 (data not shown).
###end p 43
###begin title 44
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
HOXA13 binds to gene-regulatory regions in Tie2 and Foxf1 to facilitate gene expression.
###end title 44
###begin p 45
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 251 258 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 295 301 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 514 518 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 946 951 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 956 960 956 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1165 1169 1165 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1173 1178 1173 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1350 1351 1350 1351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1373 1378 1371 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1451 1455 1445 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1595 1599 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1603 1608 1597 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1961 1969 1955 1963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1995 1999 1989 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 2011 2016 2005 2010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 2273 2280 2267 2274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 774 780 <span type="species:ncbi:9986">rabbit</span>
(A). Left panel: Chromatin immunoprecipitation (ChIP) of heterozygous control placental chromatin using a HOXA13 antibody identified DNA sequences present in the Tie2 and Foxf1 promoter regions and confirms that HOXA13 associates with these sequences in vivo. Right panel: Parallel assays using Hoxa13 homozygous mutant placentas failed to enrich for the same DNA regions, suggesting that HOXA13's DNA binding function, which is absent in the homozygous mutant protein, is necessary for in vivo association at the Tie2 and Foxf1 loci. Input indicates positive control confirming the presence of the Tie2 and Foxf1 DNA elements in both heterozygous and homozygous mutant chromatin samples. ChIP = + HOXA13 antibody; No-AB = no antibody negative control; Pre-Im = IgG control rabbit pre-immune sera; Water = no DNA PCR control (B). Sequence analysis revealed HOXA13 binding sites (red text) in the ChIP-positive PCR amplification products for both Foxf1 and Tie2. (C) EMSA analysis of the ChIP-positive PCR amplification products confirms HOXA13 can bind these sites in a concentration-dependent manner. A13-DBD = HOXA13 DNA binding domain peptide; Cold Comp.  = the Tie2 or Foxf1 binding sites lacking radioactive labeling. (D) The HOXA13 DNA binding domain binds the DNA sequences present in the ChIP-positive region with high affinity exhibiting a Kd of 48+/-4 nM for the Foxf1 region and 27+/-1.4 nM and 22+/-1.6 nM for the two sequences present in Tie2. Error bars denote the standard error for the averaged millipolarization values at each HOXA13-DBD concentration. The DNA sequences of the Tie2 or Foxf1 promoter regions used in the assay are denoted by the color text. (E) Conversion of the Tie2 or Foxf1 binding sites to the sequence TGAC ablates the affinity of the HOXA13 DNA binding domain for these gene-specific promoter sequences. Error bars denote the standard error for the averaged millipolarization values at each HOXA13-DBD concentration. (F) In vitro assessment of the 140 bp Tie2 and 121 bp Foxf1 ChIP fragments confirms that HOXA13 can use these minimal sites to direct gene expression, confirming their capacity to function as gene-regulatory elements. Values represent average detected luciferase activity after normalization for transfection with a Renilla luciferase reporter+/-standard error.
###end p 45
###begin p 46
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 159 169 159 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10B</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 374 384 374 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10C</xref>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 572 573 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 612 617 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 620 621 616 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 700 701 694 695 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 718 736 710 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10D and 10E</xref>
Sequence analysis of the immunoprecipitated Tie2 and Foxf1 promoter regions confirmed the presence of several of the recently identified HOXA13 binding sites (Figure 10B) [71]. Next, using an electrophoretic mobility shift assay (EMSA), the HOXA13 DNA binding domain was confirmed to bind the promoter regions detected by the ChIP assay in a concentration-dependent manner (Figure 10C). Quantitation of HOXA13's affinity for the Tie2 and Foxf1 ChIP-positive regions using fluorescence polarization anisotropy revealed high affinity for the binding sites present in Tie2 (Kd = 27+/-1.4 nM and 22 nM+/-1.6 nM) and Foxf1 (Kd = 48+/-4 nM) compared to a control sequence lacking the HOXA13 binding site (Kd = 250+/-22 nM) (Figure 10D and 10E).
###end p 46
###begin p 47
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 154 164 154 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10F</xref>
###xml 309 317 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp2">[72]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Boggs1">[74]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Koon1">[78]</xref>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 625 631 625 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 652 662 652 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10F</xref>
###xml 725 729 725 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 737 742 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 836 846 836 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10F</xref>
###xml 872 878 872 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1060 1064 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1082 1087 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1089 1099 1089 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g010">Figure 10F</xref>
Next, the capacity of HOXA13 to regulate gene expression through the 140 base-pair Tie2 and 121 base-pair Foxf1 ChIP-positive DNA fragments was examined (Figure 10F). The pGL3-Basic vector was selected for this analysis based on previous studies that confirm its capacity to assess promoter/enhancer activity in vitro, including previous characterizations of HOXA13's capacity to regulate transcription from minimal promoter elements [72], [74]-[78]. In the absence of the Tie2 or Foxf1 DNA elements, the empty pGL3-basic luciferase plasmid exhibited only a minor increase in luciferase expression when co-transfected with a Hoxa13 expression plasmid (Figure 10F). Similarly, the same luciferase vector containing either the Tie2 or the Foxf1 ChIP-positive regions also exhibited minimal luciferase expression in the absence of HOXA13 (Figure 10F). Co-transfection with a Hoxa13 expression vector stimulated luciferase expression from these minimal promoter elements resulting in low but significant increases in normalized luciferase expression: 3.7 fold for Tie2 and 3.2 fold for Foxf1 (Figure 10F).
###end p 47
###begin title 48
Discussion
###end title 48
###begin title 49
HOXA13 Function Is Co-Opted in Labyrinth Vascular Endothelia
###end title 49
###begin p 50
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hox</italic>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Downs2">[5]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-deSantaBarbara1">[79]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Yokouchi1">[83]</xref>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler2">[84]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morgan1">[80]</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler2">[84]</xref>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Godwin1">[85]</xref>
###xml 1188 1192 1188 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Boudreau1">[86]</xref>
###xml 1193 1197 1193 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Rhoads1">[89]</xref>
While the timing of Hoxa13 expression at E7.75 was surprising for a 5' Hox gene, its localization to the allantoic bud is consistent with the later functions of HOXA13 in the gut, where the contributing posterior allantoic bud mesoderm receives patterning instructions from the 5' HOX proteins [5], [28], [29], [79]-[83]. The vascular-specific expression of Hoxa13 appears to be restricted to the placental labyrinth, genital tubercle, and umbilical arteries; structures whose ontogeny can be linked to tissues within the posterior embryo [28],[29],[73],[84]. Here, the mesenchymal functions of HOXA13 during genitourinary development appear co-opted to facilitate vascular specification of the labyrinth endothelia [28],[29],[73],[80],[84]. HOXC13 also exhibits co-opted function in the hair follicle, suggesting that the development of specialized structures may utilize the co-opted functions of the group 13 HOX proteins [85]. While other Hox proteins such as HOXD3, HOXB3, HOXA5, and HOXD10 have been shown to regulate angiogenesis, our analysis of HOXA13's function in the vascular endothelia represents, to our knowledge, the only group 13 HOX protein functioning in this capacity [86]-[89].
###end p 50
###begin p 51
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-FromentalRamain1">[27]</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Warot1">[29]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Adams1">[49]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Yang1">[53]</xref>
###xml 302 308 302 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 466 472 466 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
In the absence of HOXA13 function, labyrinth endothelial cell integrity and vessel branching are compromised, resulting in a placental labyrinth incapable of sustaining fetal growth beyond mid-gestation [27]-[29]. Placental insufficiency also causes secondary cardiac defects [49]-[53]. The absence of Hoxa13 expression in the early cardiac field as well as its absence in the affected heart tissues supports the conclusion that thinning of the ventricular walls in Hoxa13 mutants is a secondary defect caused by placental insufficiency.
###end p 51
###begin title 52
Are HOXA13-Deficient Endothelia Assuming a Different Cell Fate?
###end title 52
###begin p 53
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 455 480 455 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyve-1, Igfbp3, Selenbp1,</italic>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ednrb</italic>
###xml 492 499 492 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000073-t002">Table 2</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Dubuisson1">[54]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Jiang1">[56]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Novosyadlyy1">[58]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-MoutaCarreira1">[90]</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Petrova1">[92]</xref>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Dubuisson1">[54]</xref>
###xml 843 849 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyve-1</italic>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Kilic1">[91]</xref>
###xml 961 965 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Petrova1">[92]</xref>
###xml 1157 1165 1157 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Selenbp1</italic>
###xml 1242 1246 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Dubuisson1">[54]</xref>
The over-expression of non-capillary endothelial genes in Hoxa13 homozygous mutant labyrinths raises an intriguing possibility that the vascular endothelia are trans-differentiating towards a sinusoidal or lymphatic phenotype. Indeed, the genes exhibiting the highest degree of over-expression in Hoxa13 mutant placentas are either elevated during lymphatic re-specification or have discrete functions in sinusoidal and/or lymphatic endothelia including: Lyve-1, Igfbp3, Selenbp1, and Ednrb (Table 2) [54], [56]-[58], [90]-[92]. Moreover, the rounded phenotype of Hoxa13 mutant EC is also more similar to sinusoidal EC, although our analysis of the mutant endothelia by TEM did not reveal substantial fenestrations usually present in sinusoidal endothelia [54]. Perturbations in the expression of the transcription factor, PROX1, also promote Lyve-1 over-expression in vascular endothelia, suggesting some degree of plasticity in endothelial specification [91],[92]. Transformations of sinusoidal endothelia towards a capillary phenotype have also been induced by selenium, thus the over-expression of the selenium binding protein in the mutant endothelia (Selenbp1), could alter endothelial specification by limiting selenium bioavailability[54].
###end p 53
###begin p 54
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-MoutaCarreira1">[90]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Gale2">[93]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Savani1">[97]</xref>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Petrova1">[92]</xref>
###xml 531 537 531 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp1</italic>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Ge1">[55]</xref>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
Alternatively, it is possible that the over-expression of LYVE1 in Hoxa13 homozygous mutant EC could affect the uptake and degradation of matrix hyaluronan, impacting endothelial cell adhesion [90], [93]-[97]. While mice lacking LYVE1 do not exhibit defects in the placental labyrinth, its over-expression in Hoxa13 mutant EC may influence how these cells interact with the underlying basement membrane resulting in the rounded appearance and perturbations in EC migration [92]. Arguing against this possibility is the result that Hoxa13 homozygous mutant EC are competent to migrate during angiogenesis, suggesting that LYVE1 over-expression in the mutant EC is a consequence of the loss of endothelial specification. Finally, the over-expression of the metalloprotease, Bmp1, could also contribute to the loss in labyrinth vascularization as BMP1 cleaves placental PROLACTIN to produce a potent angiogenic inhibitor [55].
###end p 54
###begin title 55
Loss of HOXA13 Function Does Not Affect Trophoblast Development
###end title 55
###begin p 56
###xml 148 151 148 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Downs2">[5]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Hemberger1">[13]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morasso1">[22]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Barak1">[50]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Itoh1">[51]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Yang1">[53]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-AnsonCartwright1">[62]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Li1">[63]</xref>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Basyuk1">[98]</xref>
###xml 200 205 200 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Steingrimsson1">[102]</xref>
###xml 258 272 258 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gcm1, Id1, Id2</italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpbp</italic>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Esx1</italic>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 767 772 767 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Monkley1">[103]</xref>
###xml 773 778 773 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Uehara1">[104]</xref>
###xml 928 934 928 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1031 1034 1031 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Rossant1">[1]</xref>
###xml 1035 1040 1035 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Tarkowski1">[105]</xref>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
Previous studies of labyrinth development suggest that signals from the trophoblast lineages participate in labyrinth formation and vascularization [5], [13], [22], [50], [51], [53], [62], [63], [98]-[102]. The normal expression of trophoblast genes such as Gcm1, Id1, Id2 (chorionic); Tpbp (spongiotrophoblast); and Esx1 (labyrinth trophoblast) in Hoxa13 mutant placentas suggests that trophoblast tissues are not affected by the loss of HOXA13 function. Instead, HOXA13 appears to be functioning in the vascular endothelia where it regulates pro-vascular genes necessary for labyrinth vascular development. Similar labyrinth defects are also seen in mice lacking WNT2 and HGF which appear to be predominantly expressed in the allantoic mesoderm and its derivatives [103],[104]. Finally, the normal expression of trophoblast-specific genes also suggests that tetraploid chimeras consisting of a wild type tetraploid embryo and Hoxa13 homozygous mutant embryonic stem cells would not be effective in rescuing the labyrinth defects [1],[105].
###end p 56
###begin title 57
HOXA13 Coordinates Pro-Vascular Gene Expression To Facilitate Labyrinth Formation
###end title 57
###begin p 58
###xml 3 13 3 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 153 158 153 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Hersh1">[106]</xref>
###xml 159 164 159 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Weatherbee1">[108]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morgan1">[80]</xref>
###xml 665 710 665 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuropilin-1, Enpp2, Lyve1, Caveolin-1, Foxf1</italic>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
In Drosophila, HOX proteins such as UBX regulate the formation of specific structures by controlling genes at multiple levels of a developmental cascade [106]-[108]. Our analysis of HOXA13 function during limb, genitourinary, and placental development suggests a similar mode of gene regulation where the combinatorial functions of direct and indirect target genes are coordinated to facilitate the formation of specific tissues and structures [28], [71]-[73],[80]. Evidence for this coordination is seen in the labyrinth endothelia where genes necessary for cell adhesion and vascular branching are concomitantly affected by the loss of HOXA13 function including: Neuropilin-1, Enpp2, Lyve1, Caveolin-1, Foxf1, and Tie2, resulting in hypomorphic levels of the provascular factors necessary for labyrinth vascular development.
###end p 58
###begin p 59
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Patan1">[39]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Sato2">[70]</xref>
###xml 539 544 539 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Ward1">[109]</xref>
###xml 392 396 <span type="species:ncbi:10090">Mice</span>
The binding of HOXA13 to the Tie2 and Foxf1 gene regulatory elements in vivo and the reduction of Tie2 and Foxf1 expression in Hoxa13 mutant labyrinths suggest that these pro-vascular genes are direct targets of HOXA13 in the labyrinth endothelia. Indeed, the loss of function phenotypes associated with Tie2 and Foxf1 are consistent with the endothelial defects in Hoxa13 mutant labyrinths. Mice lacking TIE2 exhibit lethality by E10.5 due to a severe lack of angiogenic branching and remodeling of the primary vascular network [39],[70],[109].
###end p 59
###begin p 60
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Mahlapuu2">[21]</xref>
###xml 55 60 55 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Ormestad1">[110]</xref>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Mahlapuu1">[20]</xref>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Mahlapuu3">[66]</xref>
###xml 62 66 <span type="species:ncbi:10090">Mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
Foxf1 is also essential for placental development [21],[110]. Mice lacking Foxf1 exhibit mid-gestational lethality resulting from defects in the patterning and vascularization of extra-embryonic tissues [20]. Interestingly, Foxf1 haploinsufficiency also affects vascular integrity, causing hemorrhaging in the lung and foregut, suggesting that reduced Foxf1 in the Hoxa13 mutant labyrinth may be sufficient to affect EC integrity and vessel branching [66]. Similarly, mice lacking ENPP2 also exhibit defects in allantois, yolk sac, and embryonic vessel formation, suggesting that this previously identified HOXA13 target gene may function to mediate labyrinth vascularization.
###end p 60
###begin title 61
Role of HOXA13 Indirect Target Genes
###end title 61
###begin p 62
###xml 12 37 12 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuropilin-1, Caveolin-1,</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 214 238 214 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuropilin-1, Caveolin-1</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 289 295 289 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Kawasaki1">[14]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Soker1">[15]</xref>
###xml 530 535 530 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Herzog1">[111]</xref>
###xml 536 541 536 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Takashima1">[113]</xref>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 692 702 692 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">caveolin-1</italic>
###xml 805 810 805 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Frank1">[114]</xref>
###xml 811 816 811 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Woodman1">[117]</xref>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
Because the Neuropilin-1, Caveolin-1, and CD36 promoter regions were not detected by the HOXA13 ChIP assay, we are presently classifying these genes as indirect targets of HOXA13. Developmentally, perturbations in Neuropilin-1, Caveolin-1, and CD36 expression are also consistent with the Hoxa13 mutant labyrinth defects. NEUROPILIN-1, a receptor for VEGF, PlGF-2, and VEGF-B, is essential for endothelial migration and proliferation, and mice lacking this protein die at mid-gestation from vascular and heart defects [14], [15], [111]-[113]. The caveolae-associated molecules CD36 and CAVEOLIN-1 also modulate cell mobility and permeability, angiogenesis, and intracellular trafficking, and caveolin-1 knockout mice exhibit decreased vascular tone and decreased angiogenic responses to exogenous stimuli [114]-[117].
###end p 62
###begin title 63
Labyrinth Formation Requires Non-Sprouting and Sprouting Angiogenesis
###end title 63
###begin p 64
###xml 237 245 237 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">Figure 2</xref>
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Rossant1">[1]</xref>
###xml 251 256 251 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Mo1">[118]</xref>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYR61</italic>
###xml 612 620 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g002">Figure 2</xref>
###xml 622 627 622 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Mo1">[118]</xref>
###xml 745 749 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Fischer1">[41]</xref>
###xml 751 756 751 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Gale3">[119]</xref>
###xml 757 762 757 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Liu2">[121]</xref>
###xml 790 796 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hey1</italic>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hey2</italic>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Fischer1">[41]</xref>
###xml 935 940 935 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Gale3">[119]</xref>
###xml 941 946 941 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Liu2">[121]</xref>
###xml 985 989 985 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DLL4</italic>
###xml 1124 1129 1124 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Gale3">[119]</xref>
###xml 1362 1367 1362 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Gale3">[119]</xref>
###xml 1447 1453 1447 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1519 1533 1519 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13, Notch1</italic>
###xml 1539 1543 1539 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dll4</italic>
###xml 1867 1873 1867 1873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1887 1893 1887 1893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notch1</italic>
###xml 1899 1908 1899 1908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hey1/Hey2</italic>
###xml 1917 1921 1917 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Fischer1">[41]</xref>
Factors regulating sprouting and non-sprouting angiogenesis are required for labyrinth development. Initially, non-sprouting angiogenesis regulated by factors such as CYR61 are required to produce the network of chorionic plate vessels (Figure 2) [1],[118]. While Hoxa13 and CYR61 homozygous mutants both exhibit reductions in labyrinth vascularization, the vascularization defects are more severe in CYR61 mutants, a consequence of the earlier developmental function of CYR61 which regulates the formation of chorionic plate vessels whose subsequent branches form the primary vessels of the vascular labyrinth (Figure 2) [118]. Similarly, defects in labyrinth vascularization have also been attributed to perturbations in NOTCH/DELTA signaling [41], [119]-[121]. In particular the loss of Notch1 function or its target genes, Hey1 and Hey2, cause a complete loss of angiogenic sprouting necessary to form the vascular labyrinth [41], [119]-[121]. Similar to HOXA13, the NOTCH ligand, DLL4, appears to be expressed in the umbilical arteries, as well as the developing chorionic plate vessels and invading labyrinth branches [119]. In these tissues, haploinsufficiency of DLL4 was sufficient to cause gestational lethality, a consequence of the regression of the chorionic plate vessels which integrate the developing umbilical vessels to the placental labyrinth [119]. While this phenotype is substantially different from the labyrinth defects in Hoxa13 homozygous mutants the similarities in the expression domains of Hoxa13, Notch1, and Dll4 raise the possibility that HOXA13 and activated Notch receptors function through common factors to promote the angiogenic processes necessary for labyrinth development. Factors such as NEUROPILIN-1 may be a common link between HOXA13 and NOTCH/DELTA signaling as this essential pro-angiogenic molecule is down-regulated in Hoxa13 (this work), Notch1, and Hey1/Hey2 mutants [41].
###end p 64
###begin p 65
###xml 433 439 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
The formation of a functional placenta is one of the most critical steps in human and mouse intrauterine development. In this study we have identified a role for HOXA13 in the formation of this vital organ. These findings suggest that HOXA13 regulates a series of genes in the vascular endothelia that are necessary for adhesion and vessel branching, providing a functional explanation for the mid-gestational lethality exhibited by Hoxa13 mutant mice. More importantly, these findings provide a novel genetic pathway to consider when characterizing pathologies of the placenta or placental evolutionary ontogeny.
###end p 65
###begin title 66
Materials and Methods
###end title 66
###begin title 67
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13-GFP</italic>
###xml 18 22 <span type="species:ncbi:10090">Mice</span>
Hoxa13-GFP Mutant Mice
###end title 67
###begin p 68
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13-GFP</italic>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morgan1">[80]</xref>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Stadler1">[28]</xref>
###xml 91 95 <span type="species:ncbi:10090">Mice</span>
All animal care and handling was done following an approved institutional animal protocol. Mice used in this study were from the Hoxa13-GFP line, previously described [28]. Hoxa13 mutant embryos were derived from heterozygous intercrosses as described [28],[80]. Timed matings were used to establish embryonic gestational age and are depicted in embryonic days (E) where E0.5 represents the first day of vaginal plug detection. The Hoxa13 mutant allele encodes a fusion protein where the last 34 amino acids of HOXA13, which encodes the DNA binding domain, have been replaced with an EGFP reporter as described [28],[73]. The nuclear localization, protein turnover, and tissue-specific expression of the HOXA13-GFP protein were similar to the wild type protein [28]. The HOXA13-GFP fusion protein produces a robust fluorescent signal. Analyses examining endogenous HOXA13-GFP localization are labeled as HOXA13-GFP. Because E11.5-13.5 placentas exhibit high autofluorescence in the GFP emission spectra it was necessary to use a GFP antibody (AB3080, Chemicon) to visualize the co-localization of the HOXA13-GFP with candidate target gene proteins. Characterizations of HOXA13-GFP expression using the GFP antibody are denoted as alpha-GFP in the figures. A Texas-red labeled secondary antibody (Jackson Immunological) was used to detect the localization of the GFP antibody.
###end p 68
###begin title 69
Immunohistochemistry and In Situ Hybridization
###end title 69
###begin p 70
###xml 430 437 414 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 511 515 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 516 520 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morgan1">[80]</xref>
###xml 526 530 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpbp</italic>
Placentas were dissected in cold 1x PBS and fixed 3 hours to overnight in 4% paraformaldehyde/PBS at 4degreesC rocking. For frozen sections, placentas were treated with a 10-30% sucrose/PBS gradient, embedded in OCT (Tissue-Tek, Inc), and stored at -80degreesC. Frozen OCT-embedded placentas were sectioned at 17-20 microm using a Leitz Kryostat 1740 and mounted on Superfrost plus slides (Fisher). Immunohistochemistry (IHC) and in situ hybridization (ISH) experiments were carried out as previously described [73],[80]. The Tpbp riboprobe plasmid was kindly provided by Dr. James Cross (University of Calgary).
###end p 70
###begin p 71
For whole placenta IHC, placentas were bisected with a double-edged razor blade and fixed in 4% paraformaldehyde overnight at 4degreesC. After fixation the bisected placentas were dehydrated with a 4:1:1 methanol-DMSO-peroxide solution and incubated in primary and secondary antibodies overnight followed by extensive PBST washes. The following antibodies and dilutions were used: PECAM-1 for section (#550274, BD Pharmingen, 1:200), PECAM-1 for whole placenta IHC (MEC13.3, #553369 BD Pharmingen, 1:200), GFP (AB3080, Chemicon, 1:100), Lyve1 (ab14917, Abcam, 1:200), Tie2 (#MAB1148, Chemicon, 1:200), ENPP2 (Cosmo Bio, 1:100).
###end p 71
###begin p 72
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morgan1">[80]</xref>
For co-localization studies, CY5- or Texas Red-labeled secondary antibodies were used as described [73],[80]. To visualize the co-localization of PECAM-1 and LYVE1 in the vascular endothelia, the red CY5 signal detecting the distribution of the PECAM-1 antibody was pseudo-colored green using the Laser Sharp 2000 software (BioRad).
###end p 72
###begin title 73
Transmission Electron Microscopy (TEM)
###end title 73
###begin p 74
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
E11.5 placentas were bisected and immediately immersed in 1.5% glutaraldehyde/1.5% paraformaldehyde with 0.05% tannic acid and 5.0% sucrose in DMEM media for 2 hours on ice, rinsed in several changes of DMEM, then post-fixed in 1.0% OsO4 in DMEM for an additional 90 minutes on ice. Fixed tissues were rinsed in several changes of DMEM over 15 minutes, then dehydrated in a graded ethanol series to 100%, rinsed in propylene oxide, and finally infiltrated and embedded in Spurr's epoxy. Ultrathin sections were cut at 80 nm, contrasted with uranyl acetate and lead citrate, and then examined using a Philips 410 TEM operated at 80 KV. E13.5 placentas were fixed by perfusion using 1.5% glutaraldehyde/1.5% paraformaldehyde with 0.05% tannic acid in DMEM, then bisected and immersed in the same fixative for an additional 60 minutes. Post-fixation, dehydration and embedding was identical to the E11.5 embryos described above.
###end p 74
###begin title 75
Morphological Scoring of the Labyrinth Endothelia
###end title 75
###begin p 76
###xml 685 691 681 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 747 753 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
E13.5 placentas were sectioned at 1 microm, mounted on slides, and counterstained with toluidine blue with basic fushin and the sections containing the labyrinth regions were photographed. For each placental sample, seven to ten photographs representing nearly the complete vascular labyrinth region were taken. Within each photo, fetal labyrinth lumens were identified, and all ECs with a visible nucleus were counted and their morphology scored as either normal (smooth elongated EC layer and lumen), intermediate (some cell rounding or irregular shape), or abnormal (cell detachment, edema, diminished cell body). Three wild type placentas (25 photos; 1510 endothelial cells), five Hoxa13 heterozygous placentas (38 photos; 1938 ECs), and five Hoxa13 homozygous mutant placentas (39 photos; 1301 ECs) were analyzed. The average percentage of each cell morphology was calculated and plotted with their standard deviations using Excel (Microsoft).
###end p 76
###begin title 77
Quantitative Analysis of Placenta Labyrinth Thickness and Vascular Branching
###end title 77
###begin p 78
###xml 207 211 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tpbp</italic>
###xml 215 221 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Placental labyrinth thickness was measured in 8 independent E12.5 Hoxa13 heterozygous and homozygous mutant placentas. The placentas were fixed, OCT embedded, and 20 microm sections were hybridized with the Tpbp or Hoxa13 (not shown) riboprobes to identify the labyrinth and overlying spongiotrophoblast regions. Digital photographs were taken from two separate placental sections that represent middle regions of each placenta, using a Leica DML light microscope with a 10x objective and a Q-Imaging camera. Using the NIH Image J software, labyrinth thicknesses (in micrometers) were measured from the labyrinth-spongiotrophoblast border to the chorionic plate at five independent points along the placental section. For each point, three to six independent measurements were taken. The average thickness and standard deviation was calculated using Excel (Microsoft) and plotted using Sigmaplot 9.0 (Systat).
###end p 78
###begin p 79
###xml 120 125 120 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Coan1">[122]</xref>
###xml 590 591 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Labyrinth vessel branching was quantitated using a modified grid analysis of the labeled labyrinth vessels as described [122]. Hemisected E13.5 placentas were fixed in 4 percent paraformaldehyde and processed for whole mount immunohistochemistry using the PECAM-1 antibody as described earlier. The hemisected placentas were photographed using a Leica MZ-12.5 stereoscope fitted with a Nikon Coolpix 990 digital camera at 4x magnification. Placenta photographs were resized to 4x2.5 inches using Adobe Photoshop CS3. Three hemisected placentas were characterized for each genotype. A 400 mm2 (20 mmx20 mm) grid was placed at six independent locations in the labyrinth region of the placental photographs and the PECAM-1 labeled vessels branches present in the grid were counted. The average number of vessel branches and their standard deviations were calculated using Excel (Microsoft) and plotted using Sigmaplot 9.0 (Systat).
###end p 79
###begin title 80
Angiogenesis Assay
###end title 80
###begin p 81
###xml 418 423 418 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Nicosia1">[123]</xref>
###xml 1191 1195 1189 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 1196 1200 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Morgan1">[80]</xref>
###xml 680 686 <span type="species:ncbi:9913">bovine</span>
Primary umbilical arteries entering the placenta (E13.5 embryos) were dissected free using sterilized tungsten needles. The dissected vessels were cut into 1-3 mm sections using sterilized microvasculature scissors (Fine Science Tools) and embedded into 1 percent type I collagen (BD Biosciences) containing 2.3 mg/ml sodium bicarbonate, and 2x enrichment of EGM-2 MV base media (Lonza, Walkersville, MD) as described [123]. Four-well chambered microslides (NUNC) were used for the embedding and culture of the vessel sections. After 10 minutes of incubation at 37 degrees Celsius, the chambered slides were filled with complete 1x EGM-2MV media supplemented with 5 percent fetal bovine serum, and the Single-Quot(R) growth factor/antibiotic cocktail containing hydrocortisone, hFGF-B, VEGF, IGF, ascorbic acid, EGF, gentamicin, and amphotericin-B as described by the manufacturer (Lonza, Walkersville, MD). After five days, the cultured umbilical arteries were fixed overnight in 4 percent paraformaldehyde/PBS at 4 degrees Celsius. After fixation the cultured vessels were rinsed with 1x PBS containing 1% Triton X 100, and characterized for HOXA13-GFP and PECAM-1 expression as described [73],[80].
###end p 81
###begin title 82
Quantification of the Ventricular Wall Thickness
###end title 82
###begin p 83
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Shaut1">[73]</xref>
###xml 584 592 584 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000073-g008">Figure 8</xref>
Three separate E13.5 Hoxa13 heterozygous control and homozygous mutant embryos were fixed, paraffin-embedded, sectioned, and stained with hematoxylin and eosin using standard histological techniques as described [73]. The heart regions from the sectioned embryos were photographed using a Leica DML compound microscope and a Q-Imaging digital camera. The cellular thickness of each ventricular wall was determined by counting the number of hematoxylin-stained nuclei present in 6-10 perpendicular lines drawn from outer edge of the left ventricular wall to the trabeculae as shown in Figure 8. The average cell number and standard deviation was calculated using Excel (Microsoft).
###end p 83
###begin title 84
Microarray and Statistical Analysis
###end title 84
###begin p 85
###xml 714 720 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
E13.5 placentas were dissected and the isolated umbilical vessels, embryonic labyrinth, and spongiotrophoblasts tissues were used as the source for the embryonic placental RNA. Tissues were dissected in RNAlater (Ambion), flash-frozen in liquid nitrogen, and stored at -80degreesC. The RNA STAT-60 (CS-110, Tel-Test, Inc.) and RNeasy Micro Kit (QIAGEN) systems were used for RNA extraction, following the manufacturer's protocol. RNA quality was assessed using an Agilent Bioanalzyer at the OHSU Affymetrix Microarray Core facility (AMC), UV spectroscopy, and agarose gel electrophoresis. Three RNA samples of like genotype were pooled for each microarray analysis. Twelve independent microarray hybridizations (6 Hoxa13 homozygous mutant, 6 wild type) were performed using the MOE430A and B microarrays (Affymetrix). MAS 5.0 software (Affymetrix) was used by the AMC to collect and normalize the array data. Statistical analysis of the microarray data sets was performed by the Biostatistics and Bioinformatics Shared Resources Core Facility at OHSU. A two-factor analysis of variance (ANOVA) was used to determine the false discovery rate and to compare transcript signal intensities between wild type and homozygous mutant placental tissues.
###end p 85
###begin title 86
Collection of Placenta Endothelial Cells for qRTPCR Analysis
###end title 86
###begin p 87
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 651 652 639 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
E13.5 placental EC were isolated by dissecting fresh placentas as in the microarray method. Two to three placentas of the same Hoxa13 genotype were combined. Samples were treated with 0.2% Collagenase Type IV (#17104-019, Gibco) at 37degreesC for 30 minutes, with occasional shaking. Tissue was then transferred to a Netwells Dish (Costar) and treated with digestion media (0.1% Trypsin/EDTA, 0.2% Collagenase IV, in PBS) for 30 minutes at 37degreesC using gentle pipetting to dissociate the tissue. Magnetic beads (Dynabeads M450, DYNAL Inc) were coated with PECAM-1 antibody (MEC 13.3, #553369 BD Pharmingen) as described by the manufacturer. 2.5x106 cells were dispensed into 0.7 ml micro-tubes with the Dynabeads-PECAM1 antibody (3x more beads than cells), and incubated for 1 hour at 4degreesC on rotating platform. The bead-antibody-cell complexes were isolated using a magnet and the remaining cell supernatant was collected as a PECAM(-) control. The cell complexes were gently washed with 0.1% BSA/PBS and collected for RNA extraction.
###end p 87
###begin p 88
###xml 1221 1226 1221 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gapdh</italic>
###xml 1228 1233 1228 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">actin</italic>
###xml 1239 1246 1239 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pecam-1</italic>
###xml 1284 1291 1284 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MageL-2</italic>
###xml 1297 1321 1297 1321 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAACCCACGACCAGAACC-3&#8242;</named-content>
###xml 1327 1353 1327 1353 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTAGTGTTGGCACGGTTGA-3&#8242;</named-content>
###xml 1369 1375 1369 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Necdin</italic>
###xml 1381 1407 1381 1407 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AACGCTTTGGTGCAGTTTCT-3&#8242;</named-content>
###xml 1413 1440 1413 1440 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AACACTCTGGCGAGGATGAC-3&#8242;</named-content>
###xml 1456 1461 1456 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adrb1</italic>
###xml 1467 1493 1467 1493 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGTACGTGTTGGTGAAGGA-3&#8242;</named-content>
###xml 1499 1526 1499 1526 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AAGTCCAGAGCTCGCAGAAG-3&#8242;</named-content>
###xml 1542 1547 1542 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enpp2</italic>
###xml 1553 1579 1553 1579 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCGACCTGACAATGATGAGA-3&#8242;</named-content>
###xml 1585 1612 1585 1612 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AAATCCAAACCGGTGAGATG-3&#8242;</named-content>
###xml 1632 1636 1632 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1642 1667 1642 1667 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAGGACGCTTCCACATTC-3&#8242;</named-content>
###xml 1673 1700 1673 1700 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CAACAGCACGGTATGCAAGT-3&#8242;</named-content>
###xml 1720 1725 1720 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1731 1756 1731 1756 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAGCCATACCTTCACCAA-3&#8242;</named-content>
###xml 1762 1787 1762 1787 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCATGGCATTGAAAGAGA-3&#8242;</named-content>
###xml 1805 1817 1805 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neuropilin-1</italic>
###xml 1823 1848 1823 1848 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTCCTGGCCACAGAGAAG-3&#8242;</named-content>
###xml 1854 1881 1854 1881 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCAGTGGCAGAATGTCTTGT-3&#8242;</named-content>
###xml 1901 1911 1901 1911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caveolin-1</italic>
###xml 1917 1943 1917 1943 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGAACAGGGCAACATCTAC-3&#8242;</named-content>
###xml 1949 1974 1949 1974 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCACGTCGTCGTTGAGAT-3&#8242;</named-content>
###xml 1990 1994 1990 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD36</italic>
###xml 2000 2026 2000 2026 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGTTGGCGAGAAAACCAGT-3&#8242;</named-content>
###xml 2032 2057 2032 2057 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCTCCGACTGGCATGAGA-3&#8242;</named-content>
###xml 2073 2079 2073 2079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyve-1</italic>
###xml 2085 2109 2085 2109 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCCAACGAGGCCTGTAA-3&#8242;</named-content>
###xml 2115 2141 2115 2141 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCTGGGGTTTGAGAAAAT-3&#8242;</named-content>
###xml 2160 2167 2160 2167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pecam-1</italic>
###xml 2173 2198 2173 2198 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGTGCAGAGCGGATAAT-3&#8242;</named-content>
###xml 2204 2230 2204 2230 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCACCGAAGTACCATTTCAC-3&#8242;</named-content>
###xml 2248 2253 2248 2253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actin</italic>
###xml 2259 2285 2259 2285 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTGCCATGTATGTGGCTAT-3&#8242;</named-content>
###xml 2291 2317 2291 2317 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCATAGATGGGCACGTTGT-3&#8242;</named-content>
###xml 2335 2340 2335 2340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 2345 2372 2345 2372 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACTGCCACCCAGAAGACTGT-3&#8242;</named-content>
###xml 2378 2402 2378 2402 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAAGGCCATGCCAGTGA-3&#8242;</named-content>
RNA was extracted from both the PECAM+ and PECAM- cell samples using the RNA Stat-60 (CS-110-Tel-Test, Inc.) and RNeasy Micro Kit systems (QIAGEN) and treated with DNase I (Promega) to remove genomic DNA. RNA quality was analyzed by UV spectroscopy and agarose gel electrophoresis. One microgram of RNA was used for cDNA synthesis using the Superscript First-Strand Synthesis system (Invitrogen). The SYBR-green based system of gene expression detection was utilized to quantify the relative levels of control and placenta-specific genes in each cDNA sample. To distinguish amplicons generated from genomic DNA, PCR primers were designed to span an intron-exon boundary. Melting curves were empirically determined for each primer set to establish precise temperature for data collection. Reaction amplifications were performed using a 1x SYBR Green PCR Master Mix as described by the manufacturer (Applied Biosciences). QRT-PCR reactions were performed in triplicate, and each gene primer set was tested against a minimum of four cDNA samples derived from independent RNA isolates. All qRT-PCR reactions were performed using an Applied Biosystems Model 7700 Sequence Detector. The primer sequences for the control genes (gapdh, actin, and Pecam-1) and candidate genes are as follows: MageL-2, For-5'-GAACCCACGACCAGAACC-3', Rev-5'-CTTAGTGTTGGCACGGTTGA-3' (132 bp, Ex1); Necdin, For-5'-AACGCTTTGGTGCAGTTTCT-3', Rev-5'- AACACTCTGGCGAGGATGAC-3' (134 bp, Ex1); Adrb1, For-5'-TGGTACGTGTTGGTGAAGGA-3', Rev-5'- AAGTCCAGAGCTCGCAGAAG-3' (100 bp, Ex1); Enpp2, For-5'-CCGACCTGACAATGATGAGA-3', Rev-5'- AAATCCAAACCGGTGAGATG-3' (120 bp, Ex24-25); Tie2, For-5'-TGAGGACGCTTCCACATTC-3', Rev-5'- CAACAGCACGGTATGCAAGT-3' (104 bp, Ex13-14); Foxf1, For-5'-GCAGCCATACCTTCACCAA-3', Rev-5'-GCCATGGCATTGAAAGAGA-3' (126 bp, Ex1-2); Neuropilin-1, For-5'-TGTCCTGGCCACAGAGAAG-3', Rev-5'- CCAGTGGCAGAATGTCTTGT-3' (115 bp, Ex12-13); Caveolin-1, For-5'-GGGAACAGGGCAACATCTAC-3', Rev-5'-ACCACGTCGTCGTTGAGAT-3' (136 bp, Ex1); CD36, For-5'-GAGTTGGCGAGAAAACCAGT-3', Rev-5'-GTCTCCGACTGGCATGAGA-3' (143 bp, Ex3); Lyve-1, For-5'-AGCCAACGAGGCCTGTAA-3', Rev-5'-CACCTGGGGTTTGAGAAAAT-3' (150 bp, Ex 2-3); Pecam-1, For-5'-CCAGTGCAGAGCGGATAAT-3', Rev-5'-GCACCGAAGTACCATTTCAC-3' (148 bp, Ex7-8); Actin, For-5'-CCTGCCATGTATGTGGCTAT-3', Rev-5'-CTCATAGATGGGCACGTTGT-3' (114 bp, Ex3-4); Gapdh For-5'-CACTGCCACCCAGAAGACTGT-3', Rev-5'-GGAAGGCCATGCCAGTGA-3' (147 bp).
###end p 88
###begin title 89
Chromatin Immunoprecipitation (ChIP)
###end title 89
###begin p 90
###xml 720 724 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp2">[72]</xref>
###xml 791 796 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 801 805 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 882 886 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 1128 1133 1122 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1164 1168 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1218 1223 1212 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1256 1282 1250 1276 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAGGTACAGCCCAGAGTCC-3&#8242;</named-content>
###xml 1288 1314 1282 1308 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACACCCCCAAGTTTTCTTC-3&#8242;</named-content>
###xml 1316 1321 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1354 1380 1348 1374 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCGGGCTTCTCTACTCTTA-3&#8242;</named-content>
###xml 1386 1412 1380 1406 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTTTACAAGCGCAGGTTC-3&#8242;</named-content>
###xml 1414 1418 1408 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1451 1477 1445 1471 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGAAGGGGAGTGGATAACA-3&#8242;</named-content>
###xml 1483 1509 1477 1503 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTAATCCCAGCCCTGCTGTA-3&#8242;</named-content>
###xml 1511 1515 1505 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1546 1572 1540 1566 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTCCTGTGCCAAGTTCTCC-3&#8242;</named-content>
###xml 1578 1605 1572 1599 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GACCAGATTCCACAGCCATT-3&#8242;</named-content>
Whole placentas were cut into 2 mm sections and fixed for 60 seconds in a 1% formaldehyde solution followed by treatment with 1M glycine/PBS/protease inhibitors. The fixed tissues were incubated 10 minutes in SDS lysis buffer (Upstate Biotech) and homogenized using disposable plastic dowels. The released chromatin was sheared at 4degreesC using a Biorupter sonicator (CosmoBio, Japan). Proper sonication was confirmed by agarose gel electrophoresis. A ChIP assay kit (Upstate Biotech) was used to isolate HOXA13-DNA fragments from sheared placental chromatin. Prior to ChIP, the presence of the HOXA13 protein in the sheared chromatin was confirmed by western-immunoblot using the HOXA13 antibody previously described [72]. Chromatin produced by the HOXA13-ChIP assay was examined for the Foxf1 and Tie2 promoter sequences containing the previously described HOXA13 binding sites [71] using PCR and 30 cycles of 94 degrees Celsius for 30 seconds, 54 degrees Celsius for 30 seconds, and 72 degrees Celsius for 30 seconds. Primers flanking the potential HOXA13 binding sites were selected using the genomic sequences listed for Foxf1 (Ensembl:MUSG00000042812) and Tie2 (Ensembl:MUSG00000006386). The PCR primers were: Foxf1#1 (-2368 to -2231, 138 bp), For-5'-TGAGGTACAGCCCAGAGTCC-3', Rev-5'-CACACCCCCAAGTTTTCTTC-3'; Foxf1#2 (-1284 to -1163, 122 bp), For-5'-CGCGGGCTTCTCTACTCTTA-3', Rev-5'-CCTTTTACAAGCGCAGGTTC-3'; Tie2#1 (-2413 to -2273, 141 bp), For-5'-GGGAAGGGGAGTGGATAACA-3', Rev-5'-CTAATCCCAGCCCTGCTGTA-3'; Tie2#2 (-859 to -702, 158 bp), For-5'-CTTCCTGTGCCAAGTTCTCC-3', Rev-5'- GACCAGATTCCACAGCCATT-3'. Each ChIP assay was performed at least two times using unique placenta samples in order to confirm the ChIP results.
###end p 90
###begin title 91
Electrophoretic Mobility Shift Assays and Luciferase Assays
###end title 91
###begin p 92
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp2">[72]</xref>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 447 449 443 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
The HOXA13 DNA-binding domain peptide was purified and gel shifts performed as previously described [72]. The Foxf1 and Tie2 primers described in the ChIP assay were used to amplify the genomic regions for the EMSA assay. The amplified PCR products were isolated using the QIAquick Gel Extraction Kit (Qiagen), quantified by UV spectroscopy, and sequenced to confirm the correct gene promoter sequence. PCR amplicons were radiolabeled using gamma-32P dATP (3000 Ci/mmol; 1Ci-37 GBq) and T4 polynucleotide kinase as described by the manufacturer (Promega). EMSA assays were performed using the Gel Shift Binding System following manufacturer's protocol (Promega).
###end p 92
###begin p 93
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 353 361 353 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Kayisli1">[65]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Mahlapuu3">[66]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp2">[72]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Boggs1">[74]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Kanayama1">[77]</xref>
###xml 644 649 644 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Suzuki2">[124]</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp2">[72]</xref>
###xml 866 871 866 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Suzuki2">[124]</xref>
###xml 951 955 947 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 959 964 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 1005 1012 997 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1036 1042 1024 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 1097 1101 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 1277 1281 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp2">[72]</xref>
###xml 1001 1004 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The 121 bp Foxf1 and 140 bp Tie2 DNA elements identified by ChIP to be bound by HOXA13 in the labyrinth vascular endothelia were evaluated in vitro for their capacity to facilitate gene expression in the presence of HOXA13. Based on the small size of these ChIP-positive DNA sequences as well as our previous characterization of HOXA13's relatively low in vitro transcriptional activity, a promoter- and enhancer-less luciferase reporter plasmid, pGL3-Basic (Promega), was selected for this analysis [65],[66]. The pGL3-Basic vector has been previously shown to measure minimal promoter activity with high reproducibility [71], [72], [74]-[77],[124]. Luciferase assays and cell culture were performed as previously described [71],[72]. The NG108-15 cell line (ATCC#HB-12317) was selected for the luciferase assay based on the absence of endogenous HOXA13 expression [124]. Transfections were performed in 12 well plates (Costar) using 2 microg of the Tie2 or Foxf1 luciferase vectors, 0.25 microg pRL-CMV Renilla, and 0.5 microg pCAGGS-Hoxa13 or empty pCAGGS control plasmid per well as described [71]. Cell lysates were processed to detect luciferase activity using the Dual-Glo Luciferase Assay System (Promega) in OptiPlate-96F black plates (Packard) as described (Promega) [72]. Luciferase activity was detected using a Packard Fusion Microplate Analyzer (Perkin Elmer), wells were read 3 times for 1 sec each and averaged. Three replicates of each transfection were performed and each transfection assay was repeated 3 times. Results were normalized for Renilla expression and averaged. The averaged data and standard errors were plotted using SigmaPlot 9.0 (Systat).
###end p 93
###begin title 94
Fluorescence Anisotropy
###end title 94
###begin p 95
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 373 412 373 412 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ctgtaattaaataccccccgtatttaattacag-3&#8242;</named-content>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 422 461 422 461 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-catttaataaaaaccccccgtttttattaaatg-3&#8242;</named-content>
###xml 463 468 463 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxf1</italic>
###xml 470 509 470 509 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-cttattattaaaggccccccctttaataataag-3&#8242;</named-content>
###xml 511 515 511 515 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGAC</named-content>
###xml 525 564 525 564 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-tgactgactgactgccccccagtcagtcagtca-3&#8242;</named-content>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000073-Knosp1">[71]</xref>
Quantification of HOXA13 affinity for the binding sites present in Foxf1 and Tie2 was determined by fluorescence polarization (FP) anisotropy as described [71]. Fluorescein-labeled self-annealing hairpin oligonucleotides specific for the binding sites in the ChIP-positive regions of Tie2 and Foxf1 were synthesized by Integrated DNA Technologies (Coralville, IA): Tie2#1: 5'-ctgtaattaaataccccccgtatttaattacag-3'; Tie2#2: 5'-catttaataaaaaccccccgtttttattaaatg-3'; Foxf1: 5'-cttattattaaaggccccccctttaataataag-3'; TGAC control: 5'-tgactgactgactgccccccagtcagtcagtca-3'. 1 nM of the annealed fluorescein-labeled oligonucleotides was incubated with 0-200 nM HOXA13-DBD peptide at 15 degrees Celsius and the FP values were measured using the Beacon 2000 Fluorescence Polarization System (Invitrogen). The detected millipolarization values (mP) were plotted using a non-linear least squares fit iteration as described [71]. Each data point represents an average (+/-standard error) of 3 or more independently derived mP values for each concentration of HOXA13-DBD peptide.
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
###xml 178 184 178 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
###xml 714 720 714 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hoxa13</italic>
Developmental analysis of labyrinth formation and pro-vascular gene expression. (A, B) PECAM-1 immunostaining revealed no difference in labyrinth vascular bed initiation between Hoxa13 control (+/-) and homozygous mutants at E10.5. (C-F) Hoxa13 homozygous mutants exhibit a decrease in primary vascular branching as early as E11.5 compared to wild-type controls. (E) and (F) represent higher magnification images of the PECAM-1 stained vessels depicted in (C) and (D), respectively. (G-J) TIE2 expression is reduced in the labyrinth region of Hoxa13 homozygous mutants compared to heterozygous controls at both the initial stages of labyrinth formation at E10.5 and during primary vessel branching at E12.5. (K-N) Hoxa13 homozygous mutant placental labyrinths exhibit a consistent increase in LYVE1 immunostaining compared to controls at E11.5 and E12.5.
###end p 97
###begin p 98
(1.50 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
The authors wish to thank Kent Thornburg and Chelsea Thornburg for the critical reading of this manuscript.
###end p 100
###begin title 101
References
###end title 101
###begin article-title 102
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Placental development: lessons from mouse mutants.
###end article-title 102
###begin article-title 103
Angiogenesis in embryonic development-a review.
###end article-title 103
###begin article-title 104
Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta.
###end article-title 104
###begin article-title 105
###xml 4 10 <span type="species:ncbi:10090">murine</span>
The murine allantois.
###end article-title 105
###begin article-title 106
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Early placental ontogeny in the mouse.
###end article-title 106
###begin article-title 107
###xml 25 31 <span type="species:ncbi:10090">murine</span>
Growth in the pre-fusion murine allantois.
###end article-title 107
###begin article-title 108
An investigation into early placental ontogeny: allantoic attachment to the chorion is selective and developmentally regulated.
###end article-title 108
###begin article-title 109
Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2.
###end article-title 109
###begin article-title 110
Endothelial cells and VEGF in vascular development.
###end article-title 110
###begin article-title 111
Blood vessel formation: what is its molecular basis?
###end article-title 111
###begin article-title 112
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.
###end article-title 112
###begin article-title 113
###xml 83 89 <span type="species:ncbi:10090">murine</span>
In utero angiopoietin-2 gene delivery remodels placental blood vessel phenotype: a murine model for studying placental angiogenesis.
###end article-title 113
###begin article-title 114
Genes governing placental development.
###end article-title 114
###begin article-title 115
A requirement for neuropilin-1 in embryonic vessel formation.
###end article-title 115
###begin article-title 116
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.
###end article-title 116
###begin article-title 117
###xml 104 109 <span type="species:ncbi:9606">human</span>
The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae.
###end article-title 117
###begin article-title 118
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extra-embryonic membranes.
###end article-title 118
###begin article-title 119
Placental function in development and disease.
###end article-title 119
###begin article-title 120
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Analysis of the gene regulatory program induced by the homeobox transcription factor distal-less 3 in mouse placenta.
###end article-title 120
###begin article-title 121
The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm.
###end article-title 121
###begin article-title 122
FREAC-1 contains a cell-type-specific transcriptional activation domain and is expressed in epithelial-mesenchymal interfaces.
###end article-title 122
###begin article-title 123
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Placental failure in mice lacking the homeobox gene Dlx3.
###end article-title 123
###begin article-title 124
Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois.
###end article-title 124
###begin article-title 125
Generation of conditional Cited2 null alleles.
###end article-title 125
###begin article-title 126
###xml 136 140 <span type="species:ncbi:10090">mice</span>
The Cdx4 mutation affects axial development and reveals an essential role of Cdx genes in the ontogenesis of the placental labyrinth in mice.
###end article-title 126
###begin article-title 127
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Loss of Cited2 affects trophoblast formation and vascularization of the mouse placenta.
###end article-title 127
###begin article-title 128
Hoxa-13 and Hoxd-13 play a crucial role in the patterning of the limb autopod.
###end article-title 128
###begin article-title 129
Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs.
###end article-title 129
###begin article-title 130
Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts.
###end article-title 130
###begin article-title 131
###xml 121 125 <span type="species:ncbi:10090">mice</span>
Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice.
###end article-title 131
###begin article-title 132
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation.
###end article-title 132
###begin article-title 133
Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis.
###end article-title 133
###begin article-title 134
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice.
###end article-title 134
###begin article-title 135
Klf2 is an essential regulator of vascular hemodynamic forces in vivo.
###end article-title 135
###begin article-title 136
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions.
###end article-title 136
###begin article-title 137
PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily.
###end article-title 137
###begin article-title 138
Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa.
###end article-title 138
###begin article-title 139
###xml 74 79 <span type="species:ncbi:9606">human</span>
Sequential steps during vasculogenesis and angiogenesis in the very early human placenta.
###end article-title 139
###begin article-title 140
TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth.
###end article-title 140
###begin article-title 141
Placental physiology : structure and function of fetomaternal exchange.
###end article-title 141
###begin article-title 142
The Notch target genes Hey1 and Hey2 are required for embryonic vascular development.
###end article-title 142
###begin article-title 143
The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis.
###end article-title 143
###begin article-title 144
The BTB-Kelch Protein KLEIP Controls Endothelial Migration and Sprouting Angiogenesis.
###end article-title 144
###begin article-title 145
Placental vascularisation requires the AP-1 component fra1.
###end article-title 145
###begin article-title 146
###xml 64 73 <span type="species:ncbi:7955">zebrafish</span>
Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries.
###end article-title 146
###begin article-title 147
The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching.
###end article-title 147
###begin article-title 148
Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation.
###end article-title 148
###begin article-title 149
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Structural and functional change of blood vessel labyrinth in maturing placenta of mice.
###end article-title 149
###begin article-title 150
Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development.
###end article-title 150
###begin article-title 151
PPAR gamma is required for placental, cardiac, and adipose tissue development.
###end article-title 151
###begin article-title 152
Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation.
###end article-title 152
###begin article-title 153
JunB is essential for mammalian placentation.
###end article-title 153
###begin article-title 154
Mekk3 is essential for early embryonic cardiovascular development.
###end article-title 154
###begin article-title 155
###xml 50 53 <span type="species:ncbi:10116">rat</span>
Transformation of sinusoids into capillaries in a rat model of selenium-induced nodular regenerative hyperplasia: an immunolight and immunoelectron microscopic study.
###end article-title 155
###begin article-title 156
Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor.
###end article-title 156
###begin article-title 157
The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
###end article-title 157
###begin article-title 158
Role of endothelin receptors in endothelin-1-induced morphological changes of hepatic sinusoidal endothelial fenestrae: morphometric evaluation with scanning electron microscopy.
###end article-title 158
###begin article-title 159
###xml 139 143 <span type="species:ncbi:10116">rats</span>
Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
###end article-title 159
###begin article-title 160
###xml 89 94 <span type="species:ncbi:9606">human</span>
Id2 is a primary partner for the E2-2 basic helix-loop-helix transcription factor in the human placenta.
###end article-title 160
###begin article-title 161
Involvement of Sp-1 in the regulation of the Id-1 gene during trophoblast cell differentiation.
###end article-title 161
###begin article-title 162
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta.
###end article-title 162
###begin article-title 163
The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta.
###end article-title 163
###begin article-title 164
Esx1 is an X-chromosome-imprinted regulator of placental development and fetal growth.
###end article-title 164
###begin article-title 165
Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling.
###end article-title 165
###begin article-title 166
###xml 90 95 <span type="species:ncbi:9606">human</span>
Spatial and temporal distribution of Tie-1 and Tie-2 during very early development of the human placenta.
###end article-title 166
###begin article-title 167
Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations.
###end article-title 167
###begin article-title 168
###xml 38 43 <span type="species:ncbi:9606">human</span>
Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending.
###end article-title 168
###begin article-title 169
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.
###end article-title 169
###begin article-title 170
Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system.
###end article-title 170
###begin article-title 171
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
###end article-title 171
###begin article-title 172
Elucidation, quantitative refinement, and in vivo utilization of the HOXA13 DNA binding site.
###end article-title 172
###begin article-title 173
HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis.
###end article-title 173
###begin article-title 174
HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia.
###end article-title 174
###begin article-title 175
C/EBPbeta participates in regulating transcription of the p53 gene in response to mitogen stimulation.
###end article-title 175
###begin article-title 176
Regulation of the interleukin-7 receptor alpha promoter by the Ets transcription factors PU.1 and GA-binding protein in developing B cells.
###end article-title 176
###begin article-title 177
###xml 47 52 <span type="species:ncbi:9606">human</span>
Characterization of the promoter region of the human RFP gene.
###end article-title 177
###begin article-title 178
Interaction between sterol regulatory element-binding proteins and liver receptor homolog-1 reciprocally suppresses their transcriptional activities.
###end article-title 178
###begin article-title 179
###xml 103 108 <span type="species:ncbi:9606">human</span>
Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.
###end article-title 179
###begin article-title 180
Tail gut endoderm and gut/genitourinary/tail development: a new tissue-specific role for Hoxa13.
###end article-title 180
###begin article-title 181
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia.
###end article-title 181
###begin article-title 182
###xml 67 72 <span type="species:ncbi:9031">chick</span>
Epithelial-mesenchymal signaling during the regionalization of the chick gut.
###end article-title 182
###begin article-title 183
###xml 92 97 <span type="species:ncbi:9031">chick</span>
HoxA and HoxB cluster genes subdivide the digestive tract into morphological domains during chick development.
###end article-title 183
###begin article-title 184
###xml 105 110 <span type="species:ncbi:9031">chick</span>
Coordinated expression of Abd-B subfamily genes of the HoxA cluster in the developing digestive tract of chick embryo.
###end article-title 184
###begin article-title 185
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Modelling genitourinary defects in mice: an emerging genetic and developmental system.
###end article-title 185
###begin article-title 186
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Hoxc13 mutant mice lack external hair.
###end article-title 186
###begin article-title 187
Induction of the angiogenic phenotype by Hox D3.
###end article-title 187
###begin article-title 188
Homeobox B3 promotes capillary morphogenesis and angiogenesis.
###end article-title 188
###begin article-title 189
Sustained expression of homeobox D10 inhibits angiogenesis.
###end article-title 189
###begin article-title 190
A role for Hox A5 in regulating angiogenesis and vascular patterning.
###end article-title 190
###begin article-title 191
###xml 113 118 <span type="species:ncbi:9606">human</span>
LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.
###end article-title 191
###begin article-title 192
Lymphatic reprogramming of micro vascular endothelial cells by CEA-related Cell Adhesion Molecule-1 via interaction with VEGFR-3 and Prox1.
###end article-title 192
###begin article-title 193
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.
###end article-title 193
###begin article-title 194
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
###end article-title 194
###begin article-title 195
###xml 83 88 <span type="species:ncbi:9606">human</span>
Expression of lymphatic vascular endothelial hyaluronan receptor-1 (LYVE-1) in the human placenta.
###end article-title 195
###begin article-title 196
Localisation and cellular origin of hyaluronectin.
###end article-title 196
###begin article-title 197
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
###end article-title 197
###begin article-title 198
Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.
###end article-title 198
###begin article-title 199
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine Gcm1 gene is expressed in a subset of placental trophoblast cells.
###end article-title 199
###begin article-title 200
###xml 53 59 <span type="species:ncbi:10090">murine</span>
In vitro methods for studying vascularization of the murine allantois and allantoic union with the chorion.
###end article-title 200
###begin article-title 201
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.
###end article-title 201
###begin article-title 202
The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties.
###end article-title 202
###begin article-title 203
The bHLH-Zip transcription factor Tfeb is essential for placental vascularization.
###end article-title 203
###begin article-title 204
Targeted disruption of the Wnt2 gene results in placentation defects.
###end article-title 204
###begin article-title 205
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.
###end article-title 205
###begin article-title 206
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Development of cytochalasin in B-induced tetraploid and diploid/tetraploid mosaic mouse embryos.
###end article-title 206
###begin article-title 207
Direct regulation of knot gene expression by Ultrabithorax and the evolution of cis-regulatory elements in Drosophila.
###end article-title 207
###begin article-title 208
###xml 58 73 <span type="species:ncbi:7227">D. melanogaster</span>
The UBX-regulated network in the haltere imaginal disc of D. melanogaster.
###end article-title 208
###begin article-title 209
Ultrabithorax regulates genes at several levels of the wing-patterning hierarchy to shape the development of the Drosophila haltere.
###end article-title 209
###begin article-title 210
The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development.
###end article-title 210
###begin article-title 211
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Differences in the embryonic expression patterns of mouse Foxf1 and -2 match their distinct mutant phenotypes.
###end article-title 211
###begin article-title 212
Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins.
###end article-title 212
###begin article-title 213
Neuropilin-1 is a placenta growth factor-2 receptor.
###end article-title 213
###begin article-title 214
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis.
###end article-title 214
###begin article-title 215
Caveolin, caveolae, and endothelial cell function.
###end article-title 215
###begin article-title 216
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
###end article-title 216
###begin article-title 217
The Caveolin genes: from cell biology to medicine.
###end article-title 217
###begin article-title 218
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.
###end article-title 218
###begin article-title 219
CYR61 (CCN1) is essential for placental development and vascular integrity.
###end article-title 219
###begin article-title 220
Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development.
###end article-title 220
###begin article-title 221
Essential role of endothelial Notch1 in angiogenesis.
###end article-title 221
###begin article-title 222
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.
###end article-title 222
###begin article-title 223
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Developmental dynamics of the definitive mouse placenta assessed by stereology.
###end article-title 223
###begin article-title 224
A new ex vivo model to study venous angiogenesis and arterio-venous anastomosis formation.
###end article-title 224
###begin article-title 225
Hox proteins functionally cooperate with the GC box-binding protein system through distinct domains.
###end article-title 225
###begin p 226
The authors have declared that no competing interests exist.
###end p 226
###begin p 227
###xml 89 97 <span type="species:ncbi:9606">Children</span>
###xml 99 102 <span type="species:ncbi:9606">HSS</span>
###xml 133 136 <span type="species:ncbi:9606">HSS</span>
This work was supported by funding from the March of Dimes (HSS), Shriners Hospitals for Children (HSS), and the NIH (R01 DK66539 to HSS). CAES was supported by an American Heart Association pre-doctoral research fellowship.
###end p 227

